San Francisco, CA
Septerna's mission is to make the promise of future GPCR medicines a reality for patients.
septerna.comThese are collections Septerna is a part of. Click on the collection name to view similar companies.
IPO
Unknown
Series B
$150,000,000
Series A
$100,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Septerna.